ABUS vs DPZ · P/E 5.4, rev $6.2M vs P/E 26, rev $4.94B
Arbutus Biopharma Corp (ABUS) versus Domino's Pizza Inc Common Stock (DPZ) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Domino's Pizza Inc Common Stock (DPZ) is a restaurants company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported DPZ revenue for 2025-12-28 was $4.94B. Net income was $601.7M. Revenue was up 5.0% from 2024-12-29 to 2025-12-28. DPZ currently screens at market cap $15.57B and trailing P/E 26.0.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. DPZ currently screens at market cap $15.57B and trailing P/E 26.0.
Not investment advice. Open the ABUS and DPZ stock pages for the full models.
Not investment advice.